Waldencast plc

NasdaqCM WALD

Waldencast plc Debt to Equity Ratio for the Trailing 12 Months (TTM) ending June 30, 2024: 0.29

Waldencast plc Debt to Equity Ratio is 0.29 for the Trailing 12 Months (TTM) ending June 30, 2024. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
NasdaqCM: WALD

Waldencast plc

CEO Mr. Michel Brousset
IPO Date May 12, 2021
Location United States
Headquarters 10 Bank Street
Employees 284
Sector Consumer Discretionary
Industries
Description

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

Similar companies

VERX

Vertex, Inc.

USD 52.91

0.92%

VTEX

VTEX

USD 5.95

2.23%

WFCF

Where Food Comes From, Inc.

USD 12.69

0.08%

StockViz Staff

January 15, 2025

Any question? Send us an email